Serveur d'exploration sur le Covid à Stanford

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Underage Youth and Young Adult e-Cigarette Use and Access Before and During the Coronavirus Disease 2019 Pandemic.

Identifieur interne : 000178 ( Main/Exploration ); précédent : 000177; suivant : 000179

Underage Youth and Young Adult e-Cigarette Use and Access Before and During the Coronavirus Disease 2019 Pandemic.

Auteurs : Shivani Mathur Gaiha [États-Unis] ; Lauren Kass Lempert [États-Unis] ; Bonnie Halpern-Felsher [États-Unis]

Source :

RBID : pubmed:33270127

Descripteurs français

English descriptors

Abstract

Importance

Understanding patterns of e-cigarette use and access during the coronavirus disease 2019 (COVID-19) pandemic is important because e-cigarettes may put users at risk for more severe respiratory effects and other health problems.

Objective

To examine whether underage youth and young adults who ever used e-cigarettes self-reported changes in access and use of e-cigarettes since the COVID-19 pandemic began.

Design, Setting, and Participants

A national, cross-sectional online survey study was conducted from May 6 to May 14, 2020. This sample of 4351 participants aged 13 to 24 years across the US included 2167 e-cigarette ever-users. Quota sampling was used to balance for age, sex, race/ethnicity, and 50% having ever used e-cigarettes.

Main Outcomes and Measures

Change in e-cigarette use (increase, decrease, quit, no change, and switch to another product) and access to e-cigarettes (easier or harder, and change in point-of-purchase) before and after the COVID-19 pandemic began, reasons for change, number of times e-cigarettes were used, nicotine dependence, and sociodemographic data.

Results

This study focused on 2167 e-cigarette ever-users among 4351 participants who completed the survey. Among 2167 e-cigarette users, a total of 1442 were younger than 21 years and 725 were aged 21 years or older; 1397 were female (64.5%) and 438 identified as lesbian, gay, bisexual, transgender, queer (20.2%). The survey completion rate was 40%. Since the COVID-19 pandemic began, 1198 of 2125 e-cigarette users (56.4%) changed their use: 388 individuals (32.4%) quit, 422 individuals (35.3%) reduced the amount of nicotine, 211 individuals (17.6%) increased nicotine use, 94 individuals (7.8%) increased cannabis use, and 82 individuals (6.9%) switched to other products. Participants reported that not being able to go to vape shops and product unavailability were the reasons accessing e-cigarettes was difficult after the pandemic began. Since the COVID-19 pandemic began, individuals reported purchasing from alternative retail stores (disposables, 150 of 632 [23.7%]; pod-based, 144 of 797 [18.1%]; and other e-cigarette, 125 of 560 [22.3%], ie, between 18.1% and 23.7%), purchasing online instead of retail (disposables, 115 of 632 [18.2%]; pod-based, 156 of 797 [19.6%]; and other e-cigarette, 111 of 560 [19.8%], ie, between 18.2% to 19.8%), and shifted to retail instead of online (disposables, 11 of 632 [1.7%]; pod-based, 17 of 797 [2.0%]; and other e-cigarette, 13 of 560 [2.3%], ie, between 1.7%-2.3%). Other individuals reported no change: from retail stores (disposables 262 of 632 [41.5%]; pod-based 344 of 797 [43.2%]; and other e-cigarette, 223 of 560 [39.8%], ie, between 39.8% and 43.2%) and online (disposables 94 of 632 [14.9%]; pod-based 136 of 797 [17.1%]; and other e-cigarette, 88 of 560 [15.8%], ie, between 14.9% and 17.1%). Underage youth reported e-cigarette deliveries from vape shops and/or dealers or friends who received such deliveries, and 63 of 229 (27.5%) self-reported accessing e-cigarettes without age verification. e-Cigarette users were 52% less likely to quit or reduce their use if they previously used e-cigarettes between 11 and 99 times (adjusted odds ratio, 0.48; 95% CI, 0.30-0.78), 68% less likely to quit if they previously used e-cigarettes more than 100 times (adjusted odds ratio, 0.32; 95% CI, 0.20-0.51), and 51% were less likely to quit if they were nicotine dependent (adjusted odds ratio, 0.49; 95% CI, 0.35-0.70).

Conclusions and Relevance

During the COVID-19 pandemic, youth e-cigarette users reported changes in e-cigarette use, point-of-purchase, and ability to purchase e-cigarettes without age verification. The US Food and Drug Administration and local policy makers may find these data useful to inform policies to prevent e-cigarette sales to underage youth.


DOI: 10.1001/jamanetworkopen.2020.27572
PubMed: 33270127
PubMed Central: PMC7716191


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Underage Youth and Young Adult e-Cigarette Use and Access Before and During the Coronavirus Disease 2019 Pandemic.</title>
<author>
<name sortKey="Gaiha, Shivani Mathur" sort="Gaiha, Shivani Mathur" uniqKey="Gaiha S" first="Shivani Mathur" last="Gaiha">Shivani Mathur Gaiha</name>
<affiliation wicri:level="2">
<nlm:affiliation>Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Lempert, Lauren Kass" sort="Lempert, Lauren Kass" uniqKey="Lempert L" first="Lauren Kass" last="Lempert">Lauren Kass Lempert</name>
<affiliation wicri:level="3">
<nlm:affiliation>Center for Tobacco Control Research & Education, University of California, San Francisco.</nlm:affiliation>
<country>États-Unis</country>
<placeName>
<settlement type="city">San Francisco</settlement>
<region type="state">Californie</region>
</placeName>
<wicri:orgArea>Center for Tobacco Control Research & Education, University of California</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Halpern Felsher, Bonnie" sort="Halpern Felsher, Bonnie" uniqKey="Halpern Felsher B" first="Bonnie" last="Halpern-Felsher">Bonnie Halpern-Felsher</name>
<affiliation wicri:level="2">
<nlm:affiliation>Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:33270127</idno>
<idno type="pmid">33270127</idno>
<idno type="doi">10.1001/jamanetworkopen.2020.27572</idno>
<idno type="pmc">PMC7716191</idno>
<idno type="wicri:Area/Main/Corpus">000132</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000132</idno>
<idno type="wicri:Area/Main/Curation">000132</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000132</idno>
<idno type="wicri:Area/Main/Exploration">000132</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Underage Youth and Young Adult e-Cigarette Use and Access Before and During the Coronavirus Disease 2019 Pandemic.</title>
<author>
<name sortKey="Gaiha, Shivani Mathur" sort="Gaiha, Shivani Mathur" uniqKey="Gaiha S" first="Shivani Mathur" last="Gaiha">Shivani Mathur Gaiha</name>
<affiliation wicri:level="2">
<nlm:affiliation>Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Lempert, Lauren Kass" sort="Lempert, Lauren Kass" uniqKey="Lempert L" first="Lauren Kass" last="Lempert">Lauren Kass Lempert</name>
<affiliation wicri:level="3">
<nlm:affiliation>Center for Tobacco Control Research & Education, University of California, San Francisco.</nlm:affiliation>
<country>États-Unis</country>
<placeName>
<settlement type="city">San Francisco</settlement>
<region type="state">Californie</region>
</placeName>
<wicri:orgArea>Center for Tobacco Control Research & Education, University of California</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Halpern Felsher, Bonnie" sort="Halpern Felsher, Bonnie" uniqKey="Halpern Felsher B" first="Bonnie" last="Halpern-Felsher">Bonnie Halpern-Felsher</name>
<affiliation wicri:level="2">
<nlm:affiliation>Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">JAMA network open</title>
<idno type="eISSN">2574-3805</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Consumer Behavior (statistics & numerical data)</term>
<term>Cross-Sectional Studies (MeSH)</term>
<term>Electronic Nicotine Delivery Systems (statistics & numerical data)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Male (MeSH)</term>
<term>Quarantine (statistics & numerical data)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Sexual and Gender Minorities (statistics & numerical data)</term>
<term>Surveys and Questionnaires (MeSH)</term>
<term>Tobacco Use Disorder (epidemiology)</term>
<term>United States (epidemiology)</term>
<term>Vaping (epidemiology)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent (MeSH)</term>
<term>Comportement du consommateur (statistiques et données numériques)</term>
<term>Dispositifs électroniques d'administration de nicotine (statistiques et données numériques)</term>
<term>Enquêtes et questionnaires (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Jeune adulte (MeSH)</term>
<term>Minorités sexuelles (statistiques et données numériques)</term>
<term>Mâle (MeSH)</term>
<term>Quarantaine (statistiques et données numériques)</term>
<term>Trouble lié au tabagisme (épidémiologie)</term>
<term>Vapotage (épidémiologie)</term>
<term>États-Unis (épidémiologie)</term>
<term>Études transversales (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>United States</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Tobacco Use Disorder</term>
<term>Vaping</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en">
<term>Consumer Behavior</term>
<term>Electronic Nicotine Delivery Systems</term>
<term>Quarantine</term>
<term>Sexual and Gender Minorities</term>
</keywords>
<keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr">
<term>Comportement du consommateur</term>
<term>Dispositifs électroniques d'administration de nicotine</term>
<term>Minorités sexuelles</term>
<term>Quarantaine</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Trouble lié au tabagisme</term>
<term>Vapotage</term>
<term>États-Unis</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>COVID-19</term>
<term>Cross-Sectional Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>SARS-CoV-2</term>
<term>Surveys and Questionnaires</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Enquêtes et questionnaires</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Études transversales</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>États-Unis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>Importance</b>
</p>
<p>Understanding patterns of e-cigarette use and access during the coronavirus disease 2019 (COVID-19) pandemic is important because e-cigarettes may put users at risk for more severe respiratory effects and other health problems.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>Objective</b>
</p>
<p>To examine whether underage youth and young adults who ever used e-cigarettes self-reported changes in access and use of e-cigarettes since the COVID-19 pandemic began.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>Design, Setting, and Participants</b>
</p>
<p>A national, cross-sectional online survey study was conducted from May 6 to May 14, 2020. This sample of 4351 participants aged 13 to 24 years across the US included 2167 e-cigarette ever-users. Quota sampling was used to balance for age, sex, race/ethnicity, and 50% having ever used e-cigarettes.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>Main Outcomes and Measures</b>
</p>
<p>Change in e-cigarette use (increase, decrease, quit, no change, and switch to another product) and access to e-cigarettes (easier or harder, and change in point-of-purchase) before and after the COVID-19 pandemic began, reasons for change, number of times e-cigarettes were used, nicotine dependence, and sociodemographic data.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>Results</b>
</p>
<p>This study focused on 2167 e-cigarette ever-users among 4351 participants who completed the survey. Among 2167 e-cigarette users, a total of 1442 were younger than 21 years and 725 were aged 21 years or older; 1397 were female (64.5%) and 438 identified as lesbian, gay, bisexual, transgender, queer (20.2%). The survey completion rate was 40%. Since the COVID-19 pandemic began, 1198 of 2125 e-cigarette users (56.4%) changed their use: 388 individuals (32.4%) quit, 422 individuals (35.3%) reduced the amount of nicotine, 211 individuals (17.6%) increased nicotine use, 94 individuals (7.8%) increased cannabis use, and 82 individuals (6.9%) switched to other products. Participants reported that not being able to go to vape shops and product unavailability were the reasons accessing e-cigarettes was difficult after the pandemic began. Since the COVID-19 pandemic began, individuals reported purchasing from alternative retail stores (disposables, 150 of 632 [23.7%]; pod-based, 144 of 797 [18.1%]; and other e-cigarette, 125 of 560 [22.3%], ie, between 18.1% and 23.7%), purchasing online instead of retail (disposables, 115 of 632 [18.2%]; pod-based, 156 of 797 [19.6%]; and other e-cigarette, 111 of 560 [19.8%], ie, between 18.2% to 19.8%), and shifted to retail instead of online (disposables, 11 of 632 [1.7%]; pod-based, 17 of 797 [2.0%]; and other e-cigarette, 13 of 560 [2.3%], ie, between 1.7%-2.3%). Other individuals reported no change: from retail stores (disposables 262 of 632 [41.5%]; pod-based 344 of 797 [43.2%]; and other e-cigarette, 223 of 560 [39.8%], ie, between 39.8% and 43.2%) and online (disposables 94 of 632 [14.9%]; pod-based 136 of 797 [17.1%]; and other e-cigarette, 88 of 560 [15.8%], ie, between 14.9% and 17.1%). Underage youth reported e-cigarette deliveries from vape shops and/or dealers or friends who received such deliveries, and 63 of 229 (27.5%) self-reported accessing e-cigarettes without age verification. e-Cigarette users were 52% less likely to quit or reduce their use if they previously used e-cigarettes between 11 and 99 times (adjusted odds ratio, 0.48; 95% CI, 0.30-0.78), 68% less likely to quit if they previously used e-cigarettes more than 100 times (adjusted odds ratio, 0.32; 95% CI, 0.20-0.51), and 51% were less likely to quit if they were nicotine dependent (adjusted odds ratio, 0.49; 95% CI, 0.35-0.70).</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>Conclusions and Relevance</b>
</p>
<p>During the COVID-19 pandemic, youth e-cigarette users reported changes in e-cigarette use, point-of-purchase, and ability to purchase e-cigarettes without age verification. The US Food and Drug Administration and local policy makers may find these data useful to inform policies to prevent e-cigarette sales to underage youth.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">33270127</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>12</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>12</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">2574-3805</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>3</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2020</Year>
<Month>12</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>JAMA network open</Title>
<ISOAbbreviation>JAMA Netw Open</ISOAbbreviation>
</Journal>
<ArticleTitle>Underage Youth and Young Adult e-Cigarette Use and Access Before and During the Coronavirus Disease 2019 Pandemic.</ArticleTitle>
<Pagination>
<MedlinePgn>e2027572</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2020.27572</ELocationID>
<Abstract>
<AbstractText Label="Importance">Understanding patterns of e-cigarette use and access during the coronavirus disease 2019 (COVID-19) pandemic is important because e-cigarettes may put users at risk for more severe respiratory effects and other health problems.</AbstractText>
<AbstractText Label="Objective">To examine whether underage youth and young adults who ever used e-cigarettes self-reported changes in access and use of e-cigarettes since the COVID-19 pandemic began.</AbstractText>
<AbstractText Label="Design, Setting, and Participants">A national, cross-sectional online survey study was conducted from May 6 to May 14, 2020. This sample of 4351 participants aged 13 to 24 years across the US included 2167 e-cigarette ever-users. Quota sampling was used to balance for age, sex, race/ethnicity, and 50% having ever used e-cigarettes.</AbstractText>
<AbstractText Label="Main Outcomes and Measures">Change in e-cigarette use (increase, decrease, quit, no change, and switch to another product) and access to e-cigarettes (easier or harder, and change in point-of-purchase) before and after the COVID-19 pandemic began, reasons for change, number of times e-cigarettes were used, nicotine dependence, and sociodemographic data.</AbstractText>
<AbstractText Label="Results">This study focused on 2167 e-cigarette ever-users among 4351 participants who completed the survey. Among 2167 e-cigarette users, a total of 1442 were younger than 21 years and 725 were aged 21 years or older; 1397 were female (64.5%) and 438 identified as lesbian, gay, bisexual, transgender, queer (20.2%). The survey completion rate was 40%. Since the COVID-19 pandemic began, 1198 of 2125 e-cigarette users (56.4%) changed their use: 388 individuals (32.4%) quit, 422 individuals (35.3%) reduced the amount of nicotine, 211 individuals (17.6%) increased nicotine use, 94 individuals (7.8%) increased cannabis use, and 82 individuals (6.9%) switched to other products. Participants reported that not being able to go to vape shops and product unavailability were the reasons accessing e-cigarettes was difficult after the pandemic began. Since the COVID-19 pandemic began, individuals reported purchasing from alternative retail stores (disposables, 150 of 632 [23.7%]; pod-based, 144 of 797 [18.1%]; and other e-cigarette, 125 of 560 [22.3%], ie, between 18.1% and 23.7%), purchasing online instead of retail (disposables, 115 of 632 [18.2%]; pod-based, 156 of 797 [19.6%]; and other e-cigarette, 111 of 560 [19.8%], ie, between 18.2% to 19.8%), and shifted to retail instead of online (disposables, 11 of 632 [1.7%]; pod-based, 17 of 797 [2.0%]; and other e-cigarette, 13 of 560 [2.3%], ie, between 1.7%-2.3%). Other individuals reported no change: from retail stores (disposables 262 of 632 [41.5%]; pod-based 344 of 797 [43.2%]; and other e-cigarette, 223 of 560 [39.8%], ie, between 39.8% and 43.2%) and online (disposables 94 of 632 [14.9%]; pod-based 136 of 797 [17.1%]; and other e-cigarette, 88 of 560 [15.8%], ie, between 14.9% and 17.1%). Underage youth reported e-cigarette deliveries from vape shops and/or dealers or friends who received such deliveries, and 63 of 229 (27.5%) self-reported accessing e-cigarettes without age verification. e-Cigarette users were 52% less likely to quit or reduce their use if they previously used e-cigarettes between 11 and 99 times (adjusted odds ratio, 0.48; 95% CI, 0.30-0.78), 68% less likely to quit if they previously used e-cigarettes more than 100 times (adjusted odds ratio, 0.32; 95% CI, 0.20-0.51), and 51% were less likely to quit if they were nicotine dependent (adjusted odds ratio, 0.49; 95% CI, 0.35-0.70).</AbstractText>
<AbstractText Label="Conclusions and Relevance">During the COVID-19 pandemic, youth e-cigarette users reported changes in e-cigarette use, point-of-purchase, and ability to purchase e-cigarettes without age verification. The US Food and Drug Administration and local policy makers may find these data useful to inform policies to prevent e-cigarette sales to underage youth.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gaiha</LastName>
<ForeName>Shivani Mathur</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lempert</LastName>
<ForeName>Lauren Kass</ForeName>
<Initials>LK</Initials>
<AffiliationInfo>
<Affiliation>Center for Tobacco Control Research & Education, University of California, San Francisco.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Halpern-Felsher</LastName>
<ForeName>Bonnie</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto, California.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>U54 HL147127</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>12</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>JAMA Netw Open</MedlineTA>
<NlmUniqueID>101729235</NlmUniqueID>
<ISSNLinking>2574-3805</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>JAMA Netw Open. 2020 Dec 1;3(12):e2028221</RefSource>
<PMID Version="1">33270120</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003258" MajorTopicYN="N">Consumer Behavior</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D066300" MajorTopicYN="N">Electronic Nicotine Delivery Systems</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011790" MajorTopicYN="N">Quarantine</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000072339" MajorTopicYN="N">Sexual and Gender Minorities</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014029" MajorTopicYN="N">Tobacco Use Disorder</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000072137" MajorTopicYN="N">Vaping</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>12</Month>
<Day>3</Day>
<Hour>12</Hour>
<Minute>9</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>12</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>12</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">33270127</ArticleId>
<ArticleId IdType="pii">2773494</ArticleId>
<ArticleId IdType="doi">10.1001/jamanetworkopen.2020.27572</ArticleId>
<ArticleId IdType="pmc">PMC7716191</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Addict Behav. 2018 Mar;78:120-123</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29154150</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Health Commun. 2019 Mar;34(3):290-297</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29236550</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Adolesc Health. 2004 Sep;35(3):225-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15313504</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nicotine Tob Res. 2015 Jul;17(7):847-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25481917</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Adolesc Health. 2020 Oct;67(4):519-523</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32798097</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Toxicol. 2020 Jun;94(6):2261-2262</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32303807</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Crit Care Med. 2017 Apr 15;195(8):1043-1049</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27806211</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Tob Regul Sci. 2019 Mar;5(2):94-104</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31840040</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Tob Control. 2017 Jul;26(4):471-475</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27543562</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Tob Control. 2018 Sep 15;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30219794</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Adolesc Health. 2017 Sep;61(3):385-388</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28712593</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nicotine Tob Res. 2014 Jun;16(6):655-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24336346</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Am Thorac Soc. 2014 Feb;11(2):236-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24575993</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Tob Control. 2014 Mar;23(2):133-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23467656</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Alcohol Depend. 2019 Jan 1;194:363-370</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30472577</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Tob Control. 2018 May;27(3):287-293</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28484040</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Pediatr Adolesc Med. 2002 Apr;156(4):397-403</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11929376</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Alcohol Depend. 2019 Nov 1;204:107512</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31487572</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Alcohol Depend. 2016 Oct 01;167:224-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27592270</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA Netw Open. 2018 Oct 5;1(6):e183535</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30646249</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Prev Med. 2017 Jan;94:65-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27773711</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Alcohol Depend. 2019 Jan 1;194:395-400</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30497057</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Crit Care Med. 2019 Dec 1;200(11):1392-1401</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31390877</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2019 Oct 04;68(39):839-844</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31581163</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2018 Nov 16;67(45):1276-1277</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30439875</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2019 Nov 5;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31688912</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA Pediatr. 2015 Mar;169(3):e1563</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25730697</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Adolesc Health. 2020 Jul;67(1):46-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32192827</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Californie</li>
</region>
<settlement>
<li>San Francisco</li>
</settlement>
</list>
<tree>
<country name="États-Unis">
<region name="Californie">
<name sortKey="Gaiha, Shivani Mathur" sort="Gaiha, Shivani Mathur" uniqKey="Gaiha S" first="Shivani Mathur" last="Gaiha">Shivani Mathur Gaiha</name>
</region>
<name sortKey="Halpern Felsher, Bonnie" sort="Halpern Felsher, Bonnie" uniqKey="Halpern Felsher B" first="Bonnie" last="Halpern-Felsher">Bonnie Halpern-Felsher</name>
<name sortKey="Lempert, Lauren Kass" sort="Lempert, Lauren Kass" uniqKey="Lempert L" first="Lauren Kass" last="Lempert">Lauren Kass Lempert</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidStanfordV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000178 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000178 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidStanfordV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:33270127
   |texte=   Underage Youth and Young Adult e-Cigarette Use and Access Before and During the Coronavirus Disease 2019 Pandemic.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:33270127" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidStanfordV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Tue Feb 2 21:24:25 2021. Site generation: Tue Feb 2 21:26:08 2021